Christian Frey

ORCID: 0000-0003-0496-9225
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Fluid Dynamics and Aerodynamics
  • Turbomachinery Performance and Optimization
  • Fluid Dynamics and Turbulent Flows
  • Combustion and flame dynamics
  • Advanced Numerical Methods in Computational Mathematics
  • Bladed Disk Vibration Dynamics
  • Hepatitis B Virus Studies
  • Numerical methods for differential equations
  • Aerodynamics and Acoustics in Jet Flows
  • Brake Systems and Friction Analysis
  • Vibration and Dynamic Analysis
  • Immunotherapy and Immune Responses
  • Immune Response and Inflammation
  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Tribology and Lubrication Engineering
  • Sepsis Diagnosis and Treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Intensive Care Unit Cognitive Disorders
  • Cell death mechanisms and regulation
  • Frailty in Older Adults
  • PARP inhibition in cancer therapy
  • Respiratory Support and Mechanisms

Ideaya Biosciences (United States)
2018-2025

Deutsches Zentrum für Luft- und Raumfahrt e. V. (DLR)
2015-2024

Linde (Germany)
2016-2024

Heinrich Heine University Düsseldorf
2021-2024

Düsseldorf University Hospital
2021-2024

Bundeswehrkrankenhaus
2023

University Hospital of Larissa
2021

Gilead Sciences (United States)
2011-2020

University Hospital Bonn
2016

Ford (Germany)
2015

Chronic HBV (CHB) infection suppresses virus-specific T cells, but its impact on humoral immunity has been poorly analyzed. Here, we developed a dual-staining method that utilizes hepatitis B virus (HBV) surface antigens (HBsAg) labeled with fluorochromes as "baits" for specific ex vivo detection of HBsAg-specific cells and analysis their quantity, function, phenotype. We studied healthy vaccinated subjects (n = 18) patients resolved 21), acute 11), or chronic 96) observed frequencies...

10.1172/jci121957 article EN Journal of Clinical Investigation 2018-08-07
Ary Serpa Neto Carmen Sílvia Valente Barbas Fabienne D. Simonis Antonio Artigas Jaume Canet and 95 more Rogier M. Determann James Anstey Göran Hedenstierna Sabrine N.T. Hemmes Greet Hermans M. Hiesmayr Markus W. Hollmann Samir Jaber Ignacio Martín‐Loeches Gary Mills Rupert M. Pearse Christian Putensen Werner Schmid Paolo Severgnini Roger Smith Tanja A. Treschan Edda Tschernko Marcos F. Vidal Melo Hermann Wrigge Marcelo Gama de Abreu Paolo Pelosi Marcus J. Schultz Adam Bell Bell Agreta Gecaj-Gashi Ahmet Dilek Ahmet Sukru Denker Akut Aytulun Peter Kienbaum Alastair Rose Alessandro Bacuzzi Alexandre Biasi Cavalcanti Alexandre Chan Alexandre Molin Alison Ghosh Alistair Roy Amanda Cowton Amanda Skinner Amanda Whileman Amy McInerney Ana Carolina Peçanha Andrea Cortegiani Andrej Šribar Andrew Bentley Andrew Corner Angela Pinder Anil Hormis A. Walker Antonio Artigas Ary Serpa Neto Barry Dixon Ben Creagh‐Brown Carlo Alberto Volta Carlos Airton Severo Munhoz Carly Brown Carmen Sílvia Valente Barbas Carmen Scott Caroline Wreybrown Catherine Plowright Charlotte Downes Cheryl Padilla-Harris Chloe Hughes Christian Frey Christian Putensen Christian Schlegel Christine Boyd Christine Ryan Christoph Muench Christopher Smalley Çiler Zincircioğlu Clair Harris Claire Kaloo Claire Matthews Claire Miller Claire Pegg Clare Bullock Clare Mellis Cláudio Piras Colette Seasman Cristina Santos Daniel Beraldo Daniel Collins Daniel Hadfield Daniel Hull Daniel Prado David Pogson Angela J. Rogers David M. Shaw Davide D’Antini Dawn Trodd Denise Griffin Debbie Weller Deborah S. Smith Deborah Wilson Demet Aydın Denise Donaldson Donatella Mestria

10.1016/s2213-2600(16)30305-8 article EN The Lancet Respiratory Medicine 2016-10-08

Background and Aims GS‐9688 (selgantolimod) is a toll‐like receptor 8 agonist in clinical development for the treatment of chronic hepatitis B (CHB). Antiviral activity has previously been evaluated vitro HBV‐infected hepatocytes vivo woodchuck model CHB. Here we potential to boost responses contributing viral control modulate regulatory mediators. Approach Results We characterized effect on immune cell subsets peripheral blood mononuclear cells healthy controls patients with activated...

10.1002/hep.31695 article EN cc-by Hepatology 2020-12-26

ABSTRACT Tenofovir alafenamide fumarate (TAF) is an oral phosphonoamidate prodrug of the HIV reverse transcriptase nucleotide inhibitor tenofovir (TFV). Previous studies suggested a principal role for lysosomal serine protease cathepsin A (CatA) in intracellular activation TAF. Here we further investigated CatA and other human hydrolases metabolism Overexpression or liver carboxylesterase 1 (Ces1) HEK293T cells increased TAF hydrolysis 2- 5-fold, respectively. Knockdown expression with RNA...

10.1128/aac.01834-15 article EN Antimicrobial Agents and Chemotherapy 2015-10-27
Silke Leonhardt Christian Jürgensen Josephine Frohme Donata Grajecki Andreas Adler and 95 more Michael Sigal Julia Leonhardt Julian M. Voll Jan Matthias Kruse Roland Körner Kai‐Uwe Eckardt Hans-Joachim Janssen Volker Gebhardt Marc D. Schmittner Stefan Hippenstiel Martin Witzenrath Norbert Suttorp Elisa T. Helbig Lena J. Lippert Paula Stubbemann Pinkus Tober‐Lau David Hillus Sascha S. Haenel Alexandra Horn Willi M. Koch Nadine Olk Mirja Mittermaier Fridolin Steinbeis Tilman Lingscheid Bettina Temmesfeld‐Wollbrück Thomas Zöller Holger Müller-Redetzky Alexander Uhrig Daniel Grund Christoph Ruwwe‐Glösenkamp Miriam Stegemann Kathrin Heim Ralf‐Harto Hübner Christian Drosten Victor M. Corman Bastian Opitz Martin Möckel Felix Balzer Claudia Spies Steffen Weber‐Carstens Chantip Dang‐Heine Michael Hummel Georg Schwanitz Uwe D. Behrens Maria Rönnefarth Sein Schmidt Alexander Krannich Saskia Zvorc Jenny Kollek Christof von Kalle Jan M. Doehn Christoph Tabeling Linda Jürgens Malte Kleinschmidt Sophy Denker Moritz Pfeiffer Belén Millet Pascual-Leone Luisa Mrziglod Felix Machleidt Sebastian Albus Felix Bremer Tim Andermann Carmen García Philipp Knape Philipp M. Krause Liron Lechtenberg Yaosi Li Panagiotis Pergantis Till Jacobi Teresa Ritter Berna Yedikat Lennart Pfannkuch Christian Zobel Ute Kellermann Susanne Fieberg Laure Bosquillon de Jarcy Anne Wetzel Markus C. Brack Moritz Müller-Plathe Daniel Zickler Andreas Edel Britta Stier Nils B. Müller Philipp Enghard Lucie Kretzler Lil Meyer-Arndt Linna Li Isabelle Wirsching Denise Treue Dana Briesemeister Jenny Schlesinger Daniel Wendisch Anna Luisa Hiller Sophie Brumhard Christian Frey

Abstract Background Increasing evidence suggests that secondary sclerosing cholangitis (SSC), which can lead to cirrhosis or liver failure, may be a hepatobiliary long-term complication of COVID-19. The aim this study was estimate the frequency and outcome COVID-19 sequela identify possible risk factors. Methods This observational study, conducted at University Hospital Charité Berlin Unfallkrankenhaus Berlin, Germany, involved hospitalized patients with pneumonia, including 1082 ventilated...

10.1007/s12072-023-10521-0 article EN cc-by Hepatology International 2023-04-29

CD95 (APO-1/Fas)-mediated apoptosis of hepatocytes plays a central role in the pathophysiology various human liver diseases. Hepatocyte growth factor (HGF) was shown to exert antiapoptotic functions rodent hepatocytes. We previously showed that primary (PHH) are valuable tool for investigation apoptotic processes cells. In this study, we analyzed influence HGF on CD95-mediated PHH and its molecular determinants. significantly inhibited as well cleavage caspase-8 poly (ADP-ribose)polymerase....

10.1002/hep.20138 article EN Hepatology 2004-03-01

AbstractBackground: Glucocorticoids have been used widely in conjunction with cancer therapy due to their ability induce apoptosis hematological cells and prevent nausea emesis. However, recent data including ours, suggest induction of therapy-resistance by glucocorticoids solid tumors, although it is unclear whether this happens only few carcinomas or a more common cell type specific phenomenon.Material Methods: We performed an overall statistical analysis our new obtained 157 tumor probes...

10.4161/cbt.6.2.3652 article EN Cancer Biology & Therapy 2007-02-01

GS-9620 [8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5<i>H</i>)-one] is a potent, orally bioavailable small-molecule agonist of Toll-like receptor 7 (TLR7) developed for finite treatment chronic hepatitis B viral (HBV) infection, with the goal inducing liver-targeted antiviral effect without adverse effects associated current systemic interferon-<i>α</i> (IFN-<i>α</i>) therapies. We characterized pharmacodynamic response in CD-1 mice and cynomolgus monkeys...

10.1124/jpet.113.207878 article EN Journal of Pharmacology and Experimental Therapeutics 2013-10-16

This article describes a nonlinear frequency domain method for the simulation of unsteady blade row interaction problems across several rows in turbomachinery. The capability to efficiently simulate such interactions is crucial improvement prediction vibrations, tonal noise, and impact unsteadiness on aerodynamic performance. technique presented here based harmonic balance approach has been integrated into an existing flow solver. A nontrivial issue application methods turbomachinery flows...

10.1115/gt2014-25230 article EN 2014-06-16

GS-9620 is a potent and selective oral Toll-like receptor 7 (TLR7) agonist that directly activates plasmacytoid dendritic cells (pDCs). suppressed hepatitis B virus (HBV) in animal models of chronic infection transiently activated HIV expression ex vivo latently infected peripheral blood mononuclear (PBMCs) from virally patients. Currently, under clinical evaluation for treating HBV reducing latent reservoirs HIV-infected Here, we investigated the vitro anti-HIV-1 activity GS-9620. potently...

10.1128/aac.01369-16 article EN cc-by Antimicrobial Agents and Chemotherapy 2016-11-01

Cyclophilin inhibition has been a target for the treatment of hepatitis C and other diseases, but generation potent, drug-like molecules through chemical synthesis challenging. In this study, set macrocyclic cyclophilin inhibitors was synthesized based on core structure natural product sanglifehrin A. Initial compound optimization identified valine-m-tyrosine-piperazic acid tripeptide (Val-m-Tyr-Pip) in core, stereocenters at C14 C15, hydroxyl group m-tyrosine (m-Tyr) residue as key...

10.1021/acs.jmedchem.6b01329 article EN Journal of Medicinal Chemistry 2017-01-11

Antibody-mediated clearance of hepatitis B surface antigen (HBsAg) from the circulation chronically infected patients (i.e., seroconversion) is usually associated with increased HBV-specific T cell responsiveness. However, a causative link between serum HBsAg levels and impairment intrahepatic CD8+ cells has not been established. Here we addressed this issue by using HBV replication-competent transgenic mice that are depleted circulating HBsAg, via either spontaneous seroconversion or...

10.1084/jem.20200298 article EN cc-by-nc-sa The Journal of Experimental Medicine 2020-08-05
Lenneke Haas Ariane Boumendil Hans Flaatten Bertrand Guidet Mercedes Ibarz and 95 more Christian Jung Rui P. Moreno Alessandro Morandi Finn H. Andersen Tilemachos Zafeiridis Sten Walther Sandra Oeyen Susannah Leaver Ximena Watson Carole Boulanger Wojciech Szczeklik Joerg C. Schefold Maurizio Cecconi Brian Marsh Michael Joannidis Yuriy Nalapko Muhammed Elhadi Jesper Fjølner Antonio Artigas Dylan W. de Lange Michael Joannidis Philipp Eller Raimund Helbok René Schmutz Joke Nollet Nikolaas De Neve Pieter De Buysscher Sandra Oeyen Walter Swinnen Marijana Mikačić Anders Bastiansen Andreas Husted Bård E S Dahle Christine Cramer Christoffer Sølling Dorthe Ørsnes Jakob Edelberg Thomsen Jonas Juul Pedersen Mathilde Hummelmose Enevoldsen Thomas Elkmann Agnieszka Kubisz-Pudelko Alan Pope Amy Collins Ashok Raj Carole Boulanger Christian Frey Ciaran Hart Clare Bolger Dominic W. K. Spray Georgina Randell Helder Filipe Ingeborg Welters Irina Grecu Jane C. Evans Jason Cupitt Jenny Lord Jeremy Henning Joanne L. Jones Jonathan Ball Julie North Kiran Salaunkey Laura Ortiz-Ruiz de Gordoa Louise Bell Madhu Balasubramaniam Marcela P. Vizcaychipi Maria Faulkner McDonald Mupudzi Megan Lea-Hagerty Michael Reay Michael Z. Spivey Nicholas Love Nick Spittle Nick Spittle Nigel White Patricia Williams Patrick Morgan Phillipa Wakefield Rachel Savine Reni Jacob Richard Innes Ritoo Kapoor Sally Humphreys Steve Rose Susan Dowling Susannah Leaver Tarkeshwari Mane Tom Lawton Vongayi Ogbeide Waqas Khaliq Yolanda Baird Antoine Romen Arnaud Galbois Bertrand Guidet Christophe Vinsonneau Cyril Charron Didier Thévenin

Abstract Background Sepsis is one of the most frequent reasons for acute intensive care unit (ICU) admission very old patients and mortality rates are high. However, impact pre-existing physical cognitive function on long-term outcome ICU ≥ 80 years (very (VIPs)) with sepsis unclear. Objective To investigate both short- VIPs admitted assess relation function. Design Prospective cohort study. Setting 241 ICUs from 22 European countries in a six-month period between May 2018 2019. Subjects...

10.1093/ageing/afab036 article EN Age and Ageing 2021-02-05
Dylan W. de Lange Ivo W. Soliman Susannah Leaver Ariane Boumendil Lenneke Haas and 95 more Ximena Watson C. Boulanger Wojciech Szczeklik Antonio Artigas Alessandro Morandi Finn H. Andersen Christian Jung Rui P. Moreno Sten Walther Sandra Oeyen Joerg C. Schefold Maurizio Cecconi Brian Marsh Michael Joannidis Yuriy Nalapko Muhammed Elhadi Jesper Fjølner Bertrand Guidet Hans Flaatten Philipp Eller Raimund Helbok René Schmutz Joke Nollet Nikolaas De Neve Pieter De Buysscher Walter Swinnen Marijana Mikačić Anders Bastiansen Andreas Husted Bård E S Dahle Christine Cramer Christoffer Sølling Dorthe Ørsnes Christensen Jakob Edelberg Thomsen Jonas Juul Pedersen Mathilde Hummelmose Enevoldsen Thomas Elkmann Agnieszka Kubisz-Pudelko Alan Pope Amy Collins Ashok Raj Carole Boulanger Christian Frey Ciaran Hart Clare Bolger Dominic W. K. Spray Georgina Randell Helder Filipe Ingeborg Welters Irina Grecu Jane C. Evans Jason Cupitt Jenny Lord Jeremy Henning Joanne L. Jones Jonathan Ball Julie North Kiran Salaunkey Laura Ortiz-Ruiz de Gordoa Louise Bell Madhu Balasubramaniam Marcela P. Vizcaychipi Maria Faulkner McDonald Mupudzi Megan Lea-Hagerty Michael Reay Michael Z. Spivey Nicholas Love Nick Spittle Nick Spittle Nigel White Patricia Williams Patrick Morgan Phillipa Wakefield Rachel Savine Reni Jacob Richard Innes Ritoo Kapoor Sally Humphreys Steve Rose Susan Dowling Tarkeshwari Mane Tom Lawton Vongayi Ogbeide Waqas Khaliq Yolanda Baird Antoine Romen Arnaud Galbois Christophe Vinsonneau Cyril Charron Didier Thévenin Emmanuel Guérot Guillaume Besch Guillaume Savary Hervé Mentec

Abstract Background Premorbid conditions influence the outcome of acutely ill adult patients aged 80 years and over who are admitted to ICU. The aim this study was determine such premorbid on 6 month survival. Methods Prospective cohort in 242 ICUs from 22 countries including or above, a months period an ICU between May 2018 2019. Only emergency (acute) admissions ≥ age were eligible. Patients after planned/elective surgery excluded. We measured Clinical Frailty Scale (CFS), Informant...

10.1186/s13613-024-01246-w article EN cc-by Annals of Intensive Care 2024-03-30

GS-9620 is a novel oral agonist of Toll-like receptor 7 (TLR7) in development for the treatment chronic viral hepatitis. TLR7 highly conserved innate immune expressed primarily on plasmacytoid dendritic cells and B lymphocytes. The aim this double-blind, placebo-controlled, single ascending-dose study was to investigate safety, tolerability, pharmacokinetics pharmacodynamics healthy volunteers.In total, 75 volunteers (8 subjects each 10 cohorts; 5 participated two cohorts) were randomized...

10.3851/imp2548 article EN Antiviral Therapy 2013-02-15

A computational method for performing aeroelastic analysis using either a time-linearized or an unsteady time-accurate solver the compressible Reynolds averaged Navier--Stokes (RANS) equations is described. The employs assumption of small time-harmonic perturbations and implemented via finite differences nonlinear flux routines solver. resulting linear system solved parallelized generalized minimal residual (GMRES) with block-local preconditioning. time accurate uses dual stepping algorithm...

10.1115/1.4004749 article EN Journal of Turbomachinery 2012-05-24

Development of an adaptive, International Classification Functioning, Disability and Health (ICF)-oriented patient questionnaire on mobility self-care based item response theory model (MOSES questionnaire).Using reconstruction rules, items were developed for the ICF chapters "mobility", "self-care" "domestic life". The resulting instrument, together with other instruments (SF-36, Short Musculoskeletal Function Assessment Questionnaire (SMFA), MacNew, Functional Independence Measure (FIM),...

10.2340/16501977-0083 article EN Acta Dermato Venereologica 2007-01-01

Primary cicatricial alopecias (PCA) encompass several autoimmune disorders characterized by scarring hair loss. Many of these conditions are lymphocytic and thought to be driven T cell populations. Here, we sought characterize potential cell-hair follicle communication pathways in the microanatomical niche using spatial transcriptomics across 3 mammalian species including a novel mouse model, spontaneous disease companion dogs human archival diagnostic biopsies. Flow cytometry model skin...

10.1101/2025.01.20.633953 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2025-01-24

Methylthioadenosine phosphorylase (MTAP) is co-deleted with the tumor suppressor CDKN2A in approximately 15% of solid tumors. Loss MTAP blocks cellular 1-carbon salvage pathway activity due to an inability convert MTA into adenine and methionine. Accumulation MTAP’s substrate, MTA, coincident depletion products, methionine precursors, results two distinct targetable vulnerabilities: direct S-Adenosyl (SAM)-competitive inhibition essential methyltransferase Protein arginine 5 (PRMT5), reduced...

10.1158/1538-7445.am2025-4268 article EN Cancer Research 2025-04-21

Abstract The formation of cancer and responsiveness to therapy is governed by a constantly evolving balance between somatic variation dynamic epigenetic regulation. This evolution has been recognized as significant obstacle confronting the development durable therapies. Thus, targeting reprogramming in human cancers key focus for design new drugs potentially deliver robust anti-tumor activity. Lysine acetyltransferases (KATs) are promising class targets that operate within interchangeable...

10.1158/1538-7445.am2025-442 article EN Cancer Research 2025-04-21

Abstract Poly (ADP-Ribose) glycohydrolase (PARG) is an emerging oncology drug target with a unique role in the resolution of DNA damage repair and replication fork restart through hydrolysis (ADP-ribose) (PAR) chains. IDE161 potent, orally bioavailable, small molecule that directly binds active site PARG to impede PAR chain exhibits robust anti-tumor activity preclinical models associated stress. Molecular profiling baseline cell states across 257 tumor lines indicated innate immune...

10.1158/1538-7445.am2025-2899 article EN Cancer Research 2025-04-21
Coming Soon ...